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Introduction
The extent of the problem of exposure to biological ha-
zards is certainly greater that what is often believed,
especially in those working environments without the
known presence of biological agents dangerous to
one’s health; the underestimation of the actual hazards
is in itself the greatest hazard of them all [1-6]. Legi-
slative Decree 626/94, as modified by Legislative De-
cree 242/96, represents the acceptance of Directive
89/391/EEC and the subsequent six Directives on the
safety and protection of workers’ health; among these
there is also Directive 90/679/EEC on the protection
from biological agents [7-10]. Undoubtedly, the latter
marks an important turning point for the protection of
workers from hazards due to exposure to biological
agents during work, something that is not restricted to
the prescription of hygiene standards or good micro-
biological practice, but imposes the implementation of
a whole series of obligations relative to the assessment
of the risk, workers’ information, notifications to re-
sponsible Authorities, health surveillance and specific
control measures to be adopted for the working areas.
As regards health surveillance, article 86 of title VIII
requires its implementation for those workers exposed
to biological agents, underlining the availability of ef-
fective vaccines for those workers who are not yet im-
munised [11]. Regarding this problem, the non-exten-
sion of the present range of compulsory vaccinations to
some professional categories at risk is worthy of note.
It is simply stated that the vaccine is to be made avai-
lable, or that it is to be free of charge, as in the case of
hepatitis B (former Decree of the Health Ministry 4 Oc-
tober 1991) to those workers exposed to specific infec-
tious hazards; among these workers we also find muni-
cipal solid waste workers who, regardless of their tasks
(drivers, sweepers or incinerator operators) and their
professional training, clearly perform an activity that is
at high risk of infection because of the type of material
with which they come into contact. In this situation,
beyond a generic risk of accidents, the prevention,
where possible, of those infectious diseases against
which we have effective vaccines (such as hepatitis B),
would seem not only imperative (Law 626/94 and inte-
grations) but obvious; however, as one can deduce
from the above, all this is not yet contemplated by the
legislator. The aim of our work has been to investigate,
through a seroprevalence study towards hepatitis B and
C, the serologic profiles of a sample of municipal solid
waste workers in the province of Messina, with the in-
tent to verify the reasonable hypothesis of high infec-
tious risk towards these diseases, thus further emphasi-
zing the importance of adequate prophylactic measures
within this category of workers.
Methods
Between March and May 2005, the sera of 327 munici-
pal solid waste workers, from 20 to 68 years of age, re-
sponsible for sweeping as well as collection and dispo-
sal of household waste, were analysed for the likely
presence of antibodies to hepatitis B and C viruses. The
study was carried out using the automated Abbott IMX
System, which uses the Microparticle Enzyme Immune
Assay (MEIA) method (Abbott Laboratories, Illinois,
USA). In short, this microparticle capture enzyme im-
muno-assay is an automated system for measuring spe-
cific antibody by interaction with antigen-coated parti-
cles. Having incubated the microparticles and the se-
rum being tested, the reaction mixture is transferred to
an inert glass fibre matrix to which the particles bind ir-
reversibly. The immune complex is transferred from
the glass fibres while the reaction mixture rapidly spil-
ls out of the large pores of the matrix. The detection of
the immune complexes on the glass fibre matrix is ac-
complished by using an alkaline phosphatase-marked
conjugate, which catalyses the hydrolysis of 4-methyl-
ORIGINAL ARTICLE
Study on hepatitis B and C serologic status among
municipal solid waste workers in Messina (Italy)
R. SQUERI, V. LA FAUCI, L. SINDONI, G. CANNAVÒ*, E. VENTURA SPAGNOLO*
University of Messina. Department of Hygiene, Preventive Medicine and Public Health; 
* University Hospital “G. Martino”, Health Administration, Messina, Italy
Summary
Key words
Hepatitis • Municipal solid waste workers • Seroprevalence
A study on hepatitis B and C virus seroprevalence was carried
out on blood samples from 327 municipal solid waste workers
in Messina (Italy) to verify the hypothesis that this category of
workers is at high risk for such diseases. The fact that 32.41%
of all the subjects showed previous exposure to hepatitis B virus
(HBV) substantiates the need to proceed with compulsory HBV
vaccine prophylaxis in this category of workers, also in antic-
ipation of possible medical legal litigations.
111
STUDY ON MUNICIPAL SOLID WASTE WORKERS IN MESSINA
umbellipheryl phosphate to 4-methyl–umbellipherone.
The speed at which this latter molecule is formed is
proportional to the concentration of the analyte in the
sample being tested. At the end of the laboratory as-
says, we consulted the paper records of the vaccination
office of Local Health Unit (LHU) 5 of Messina, to
identify the percentage of municipal solid waste
workers vaccinated against hepatitis B and the number
of vaccine doses administered, thus being in the posi-
tion to compare these data and the laboratory data.
Furthermore, the municipal solid waste workers were
given a questionnaire to identify the presence of risk
factors for hepatitis B and/or C. The statistical signifi-
cance tests were done according to the Pearson’s χ2
method using the Epi Info 6.04d software (Centers for
Disease Control and Prevention, Atlanta, USA).
Results and Discussion
Table I shows the immunological status of the munici-
pal solid waste workers studied relative to hepatitis B
and C virus. 120 municipal solid waste workers
(36.70%) are negative to HBV and HCV antibodies; of
these, 1.22% belong to the 20-30 age group, 12.84% to
the 31-40 age group, 11.31% to the 41-50 age group
and 11.31% to > 50 years age group. The remaining
207 (63.30%) were found to be positive to different
HBV markers, anti HCV antibodies and precedent
HBV-HCV co-infection; 7 of them (2.14%) belong to
the 20-30 age group, 51 (15.59%) to the 31-40 age
group, 72 (22.01%) to the 41-50 age group and 77
(23.54%) are over 50 years old. If we examine these re-
sults more closely we can see that in 117 municipal so-
lid waste workers there is only the presence of HbsAb,
due mainly to vaccination (98 subjects) (Tab. III) and
in the remaining 19 due to an infection. We also obser-
ved a condition indicative of recovery in 62 municipal
solid waste workers (18.96%) for the presence of HB-
sAb+/HBcAb+ or HBsAb+/HBcAb+/HBeAb+ or HB-
cAb/HBeAb; of chronic carrier in 13 subjects (3.98%)
for the presence of HBsAg+/HBcAb+/HBeAb; of chro-
nic hepatitis in 7 (2.14%) for the presence of HBcAb;
of HBV/HCV co-infection in 5 (1.53%) and finally we
found 3 workers (0.92%) with only antibodies to HCV.
Out of the 327 municipal solid waste workers, only 136
(41.59%) had been vaccinated against hepatitis, of the-
se 65 (47.79%) had completed the vaccine cycle, 46
(33.82%) had only taken two doses and 25 (18.38%)
only one dose (Tab. II). In comparing the group of
subjects that had completed the vaccine cycle and tho-
se that had taken only 1 or 2 doses, we observed that
the first group had a percentage of serum conversion si-
gnificantly higher than the second group (p < 0.01)
with a percentage of response to vaccination progressi-
vely higher with increasing number of administered do-
Tab. I. Overall serologic status of all municipal solid waste workers examined according to age groups.
Age groups (years)
Serologic profiles 20-30 31-40 41-50 > 50 total
% % % % %
HBsAb+ 7 37 34 39 117
(2.14) (11.31) (10.40) (11.93) (35.78)
HBsAb– HCVAb- 4 42 37 37 120
(1.22) (12.84) (11.31) (11.31) (36.70)
HBsAb+ HBcAb + 0 4 11 15 30
(1.22) (3.36) (4.59) (9.17)
HBsAb+ HBcAb+ HBeAb+ 0 3 14 10 27
(0.92) (4.28) (3.06) (8.26)
HBsAg+ HBcAb+ HBeAb+ 0 3 8 2 13
(0.92) (2.45) (0.61) (3.98)
HBcAb+ HBeAb+ 0 1 1 3 5
(0.31) (0.31) (0.92) (1.53)
HBcAb+ 0 0 1 6 7
(0.31) (1.84) (2.14)
HCVAb+ 0 0 3 0 3
(0.92) (0.92)
HCVAb+ HBcAb+ HBeAb+ 0 1 0 0 1
(0.31) (0.31)
HCVAb+ HBsAb+ HBcAb+ HBeAb+ 0 1 0 1 2
(0.31) (0.31) (0.61)
HCVAb+ HBsAb+ HBcAb+ 0 1 0 1 2
(0.31) (0.31) (0.61)
11 93 109 114 327
(3.36) (28.44) (33.33) (34.86)
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ses. Table III shows the serological status
of 136 vaccinated subjects and 191 non-
vaccinated ones. Among the 136 vaccina-
ted subjects, in 98 subjects (72.06%) we
detected the presence of HBsAb; 8
(5.88%) had not seroconverted while in the
remaining 30 we detected a serological sta-
tus indicative of precedent contact with the
hepatitis B virus, which resulted in a sero-
logical status of recovery in 23 subjects
(16.91%), chronic hepatitis in 2 subjects
(1.47%) and a condition of acute hepatitis
in 3 (2.21%); finally in 2 workers we de-
tected the presence of hepatitis B and he-
patitis C co-infection. Out of 191 non-vac-
cinated subjects, 61 (31.93%) showed a se-
rologic status indicating previous contact
with HBV and recovery (HBsAb, HB-
sAb/HBcAb, HBsAb/HBcAb/HBeAb,
HBcAb/HBeAb, HCVAb/HBcAb/HBeAb,
HCVAb/HBsAb/HBcAb/HBeAb, HC-
VAb/HBsAb/HBcAb), 112 (58.64%) were
found to be negative for all hepatitis B
and/or C markers, 11 (5.76%) were in the
condition of chronic hepatitis B (HBcAb),
4 (2.09%) showed a serological status of
hepatitis B in progress
(HBsAg/HBcAb/HBeAb), 3 (1.56%) had
only antibodies to HCV, and finally 3
others (1.56%) showed HBV/HCV co-in-
fection.
Tab. II. Percentage of seroconversions among the municipal solid waste workers examined relative to the number of vaccine doses and
corresponding age groups. Out of 38 HbsAb-negative subjects, 30 were positive for other markers of precedent hepatitis B infection.
vaccinated per age group HBsAb+
20-30 31-40 41-50 > 50 Total
% % % % %
1 dose 0 3 2 2 7
(3.06) (2.04) (2.04) (7.14)
2 doses 0 13 13 9 35
(13.27) (13.27) (9.18) (35.71)
3 doses 1 9 27 19 56
(1.02) (9.18) (27.55) (19.39) (57.14)
1 25 42 30 98
(1.02) (25.51) (42.86) (30.61)
vaccinated per age group HBsAb-
20-30 31-40 41-50 > 50 Total
% % % % %
1 dose 1 4 6 7 18
(2.63) (10.53) (15.79) (18.42) (47.37)
2 doses 1 2 3 5 11
(2.63) (5.26) (7.89) (13.16) (28.95)
3 doses 0 2 3 4 9
(5.26) (7.89) (10.53) (23.68)
2 8 12 16 38
(5.26) (21.05) (31.58) (42.11)
Tab. III. Serologic profiles of all municipal solid waste workers examined relative to
their vaccine status against HBV.
Serologic profiles HBV non total
vaccinated vaccinated
% % %
HBsAb+ 98 19 117
(72.06) (9.95) (35.78)
HBsAb- 8 112 120
(5.88) (58.64) (36.70)
HBsAb+, HBcAb+ 9 21 30
(6.62) (10.99) (9.17)
HBsAb+, HBcAb+, HBeAb+ 14 13 27
(10.29) (6.81) (8.26)
HBsAg+, HBcAb+, HBeAb+ 2 11 13
(1.47) (5.76) (3.98)
HBcAb+, HBeAb+ 5 5
(2.62) (1.53)
HBcAb+ 3 4 7
(2.21) (2.09) (2.14)
HCVAb+ 3 3
(1.57) (0.92)
HCVAb+, HBcAb+, HBeAb+ 1 1
(0.52) (0.31)
HCVAb+, HBsAb+, HBcAb+, HBeAb+ 1 1 2
(0.74) (0.52) (0.61)
HCVAb+, HBsAb+, HBcAb+ 1 1 2
(0.74) (0.52) (0.61)
136 191 327
(41.59) (58.41)
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Conclusions
The following conclusions can be drawn by examining
the results reported in Table III: (a) 183 municipal solid
waste workers (55.96%) are protected against HBV be-
cause of the presence of HBsAb (HBsAb, HBsAb/HB-
cAb, HBsAb/HBcAb/HBeAb, HCVAb/HBcAb/HBeAb,
HCVAb/HBsAb/HBcAb/HBeAb, HCVAb/HBsAb/HB-
cAb), almost all or 98 (53.55%) from vaccination and 85
(46.44%) from precedent contact with HBV and conse-
quent recovery, whereas 120 municipal solid waste
workers (36.70%) are at risk because of lack of protective
antibodies; the real exposure to the hepatitis B virus, do-
cumented by the presence of antibodies and antigens in
vaccinated and non vaccinated subjects, is indicated by
106 subjects, i.e. by 32.41% of all the subjects examined
in the study; among them 5 (1.52%) who had come into
contact with both HBV and HCV and 3 (0.92%) exclusi-
vely with the latter and, furthermore, 30 of the 38 subjects
that were found to be negative to HBsAb markers also
had antibodies indicating previous infection with HBV.
None of the workers, however, had any anamnesis recol-
lection of symptoms and/or specific signs; 25.43% repor-
ted accidental wounds during their working activity, no
one reported using drugs while 34.51% reported to have
had unprotected sex. The presence of serologic markers
other than HBsAb in vaccinated subjects is of particular
importance because it enables us to put forward two hy-
potheses: (a) the presence of these markers could be attri-
buted to the lack of seroconversion after the vaccine; (b)
these markers were present prior to the vaccination due to
a previous contact with the virus. Given the high percen-
tage of subjects that had come into contact with HBV
(32.41%), it would be advisable, for categories of particu-
larly high-risk workers, to check when they are hired the
serologic status before and after vaccination, both to carry
out specific procedure in case of lack of seroconversion
(additional vaccine doses or seroprophylaxis in non-re-
sponder subjects in case of accidental cuts), and for medi-
cal legal purposes. Moreover, because the antihepatitis B
vaccination has been compulsory since 1991 for all new-
borns and for 12-year-olds on that date and for subse-
quent 12 years, vaccination is recommended for subjects
over 24 years old among the categories at risk specified
by the Ministerial Decree though free of charge [11-14].
Health and vaccine surveillance, in fact, cannot be only at
the end of a process that, starting from the hazard asses-
sment, ensures adequate protection for the workers expo-
sed, but should be the starting input for effective preven-
tive measures [9, 10, 14]. Bearing in mind that, from an
insurance point of view, Italian Law equates infectious di-
seases to work-related accidents and that consequently,
these are subject to indemnity whenever a causal connec-
tion with the working activity can be demonstrated [13]
and seeing that vaccination, outside the compulsory age
group, is only recommended and the employee can refuse
to take it, it is essential for the workers to be adequately
informed on the disease, the way it is transmitted and how
it can be prevented. A consequence of this could be possi-
ble medical legal litigation undertaken by the worker who
had not been offered the vaccination and is then affected
by the infectious disease deemed to have been caught at
work. It should be stressed that, even in other European
and non-European countries the problem has been raised
with similar arguments [4-6] and, particularly Dounias
and co-workers [6], have come to conclusions that are si-
milar to ours starting from statistical and rational bases
that are essentially the same.
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